secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001558370-24-006594
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kumar Budur promoted to EVP and Chief Medical & Scientific Officer at Harmony Biosciences
--------------------------------------------------------------------------------

- Appointed EVP & Chief Medical & Scientific Officer effective May 1, 2024.
- Annual salary raised from $500,000 to $575,000; target bonus remains 50% of salary.
- Receives 75,000 RSUs and 75,000 stock options vesting over four years.
- Dr. Budur had been Chief Medical Officer; biography previously disclosed in proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/0001558370-24-006594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837024006594/hrmy-20240501x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-006594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer